People living with common allergies such as asthma, hay fever, and atopic dermatitis are at greater risk of developing depression, bipolar disorder, anxiety, and neuroticism. Researchers report the link was likely not causal.
Researchers have identified a gene that has evolved through natural selection and is implicated in psychiatric disorders and personality traits. The study suggests natural selection has helped shaped our psychiatric traits and helped to maintain human diversity.
A new study suggests a link between prenatal tobacco exposure and an increased risk of developing bipolar disorder in adult offspring.
Adults who were maltreated as children have an increased risk of being diagnosed with schizophrenia, psychosis, bipolar disorder, and anxiety than their peers who were not abused.
New research finds smoking significantly increases the risk of a person developing schizophrenia or depression.
While patients with schizophrenia, major depressive disorder, and bipolar disorder experience a lack of motivation and anhedonia, the neural patterns of emotion-behavior dissociation differ between the disorders.
A new brain tissue study has shown gene expression in bipolar patients treated with antipsychotic medications is similar to the expression in subjects with no history of bipolar disorder.
Researchers report mitochondrial dysfunction may affect the activity of serotonergic neurons in mice with ANT1 mutations. The findings may provide insight into the origins of bipolar disorder.
Researchers have identified a gene variant linked to psychotic symptoms and cognitive impairment in people with bipolar disorder.
A new study in Neuropsychopharmacology reveals an association between faster aging and bipolar depression. Researchers discovered those with bipolar disorder who did not take lithum had shorter telomere length than those with the disorder who took the medication. The study suggests reduced telomere length could reduce hippocampal neurogenesis, increasing the risk for mood disorders.
Treatment resistant bipolar disorder patients experienced a reversal of a key symptom 40 minutes after a single infusion of ketamine, a new study reports.